Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder
    Published on 2025-08-15
    1 year ago
  • The generative AI blueprint: modeling brain and behavior in concert
    Published on 2025-08-15
    1 year ago
  • Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine pain
    Published on 2025-08-14
    1 year ago
  • Epigenetic regulation of brain development, plasticity, and response to early-life stress
    Published on 2025-08-06
    1 year ago
  • Rewired realities: novel insights into the neurobiology of cannabis use disorder and psychosis
    Published on 2025-08-06
    1 year ago
  • Menstrual cycle and mental health in adolescents: a developmental neuroendocrine perspective
    Published on 2025-08-05
    1 year ago
  • The effect of the “exposome” on developmental brain health and cognitive outcomes
    Published on 2025-08-05
    1 year ago
« Previous 1 … 52 53 54 55 56 … 143 Next »
Journal of Psychopharmacology
  • Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities
    Published on 2024-06-10
    2 years ago
  • The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms
    Published on 2024-06-03
    2 years ago
  • Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights
    Published on 2024-05-28
    2 years ago
  • Changes in processing speed during early abstinence from alcohol dependence
    Published on 2024-05-28
    2 years ago
  • Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
    Published on 2024-05-14
    2 years ago
  • Aripiprazole for treating delirium: A systematic review—Is it a valid yet understudied treatment?
    Published on 2024-04-30
    2 years ago
  • Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice
    Published on 2024-04-29
    2 years ago
« Previous 1 … 52 53 54 55 56 … 154 Next »
European Neuropsychopharmacology
  • A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
    Published on 2024-03-15
    2 years ago
  • Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
    Published on 2024-03-15
    2 years ago
  • Parvalbumin interneuron deficits in schizophrenia
    Published on 2024-03-15
    2 years ago
  • The why and the how of transdiagnostic clinical research in youth psychiatry
    Published on 2024-03-15
    2 years ago
  • The pros and cons of banning electronic cigarettes
    Published on 2024-03-15
    2 years ago
  • Settling a distracted globe: An overview of psychosocial and psychotherapeutic treatment of attention-deficit/hyperactivity disorder
    Published on 2024-03-14
    2 years ago
  • Antidepressants and suicide—More benefit than harm
    Published on 2024-03-14
    2 years ago
« Previous 1 … 52 53 54 55 56 … 170 Next »

   Pharma Pub